Magee Thomson Investment Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-70,810
Closed -$6.5M 99
2016
Q1
$6.5M Sell
70,810
-1,340
-2% -$121K 2.05% 26
2015
Q4
$7.3M Sell
72,150
-62,520
-46% -$6.51M 2.01% 29
2015
Q3
$13.2M Buy
134,670
+8,450
+7% +$938K 4.08% 9
2015
Q2
$14.8M Buy
126,220
+3,650
+3% +$399K 4.29% 2
2015
Q1
$12M Sell
122,570
-77,840
-39% -$7.9M 2.91% 20
2014
Q4
$18.9M Sell
200,410
-72,690
-27% -$7.52M 4.7% 3
2014
Q3
$29.1M Sell
273,100
-10,800
-4% -$1.06M 7.16% 1
2014
Q2
$23.5M Sell
283,900
-24,700
-8% -$1.92M 5.75% 1
2014
Q1
$21.9M Buy
308,600
+1,760
+0.6% +$138K 4.97% 2
2013
Q4
$23M Sell
306,840
-72,200
-19% -$5.03M 5.1% 1
2013
Q3
$23.8M Sell
379,040
-10,400
-3% -$622K 4.79% 1
2013
Q2
$20M Buy
+389,440
New +$20.3M 4.54% 2

Other funds holding GILD

Magee Thomson Investment Partners's GILD Position: Q2 2016 in Review

Magee Thomson Investment Partners sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 70,810 shares — an estimated $6.5M sold.

Magee Thomson Investment Partners first reported a position in GILD in Q2 2013 and held it in 12 quarters. The position peaked at $29.1M in Q3 2014. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Magee Thomson Investment Partners reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • Magee Thomson Investment Partners sold 70,810 Gilead Sciences shares in Q2 2016, an estimated $6.5M.
  • Magee Thomson Investment Partners first reported a position in Gilead Sciences in Q2 2013 and held it in 12 quarters.
  • Magee Thomson Investment Partners's Gilead Sciences position peaked at $29.1M in Q3 2014.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Magee Thomson Investment Partners's 13F filing for Q2 2016, filed 21 Jul 2016.